K030102

Substantially Equivalent

ADVIA CENTAUR AND ACS:180 LIQUID CARDIAC MARKERS 1, 2, 3

Applicant: Bayer Healthcare, LLC
Product code: JJT
Advisory panel: Clinical Chemistry
Date received: 2003-01-10
Decision date: 2003-01-24
Decision: Substantially Equivalent
Clearance type: Abbreviated
Location: Tarrytown, NY, US

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.